166 related articles for article (PubMed ID: 32736785)
1. Inpatient prophylaxis in cancer patients: where is the evidence?
Patell R; Zwicker JI
Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
[TBL] [Abstract][Full Text] [Related]
2. Prediction and Prevention of Cancer-Associated Thromboembolism.
Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of venous thromboembolism in cancer patients.
Frere C; Doucet L; Farge D
Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
[TBL] [Abstract][Full Text] [Related]
5. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
Wehmeyer A; Coetzee R; McCartney J
S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
9. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
10. Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study.
Hemon F; Fouchard F; Tromeur C; Lacut K; Le Gal G; Mottier D; Couturaud F; Delluc A
Eur J Intern Med; 2017 Oct; 44():39-43. PubMed ID: 28647342
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
Dwyer JP; Javed A; Hair CS; Moore GT
Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
[TBL] [Abstract][Full Text] [Related]
12. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
[TBL] [Abstract][Full Text] [Related]
13. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
Lewis TC; Cortes J; Altshuler D; Papadopoulos J
J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
[TBL] [Abstract][Full Text] [Related]
15. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness.
Di Nisio M; Candeloro M; Rutjes AWS; Galli V; Tritto M; Porreca E
Thromb Res; 2018 Sep; 169():44-49. PubMed ID: 30015227
[TBL] [Abstract][Full Text] [Related]
16. New paradigms in venous thromboprophylaxis of medically ill patients.
Spyropoulos AC; Raskob GE
Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
[TBL] [Abstract][Full Text] [Related]
17. Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice.
McGarry LJ; Thompson D
Clin Ther; 2004 Mar; 26(3):419-30. PubMed ID: 15110135
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
Lyman GH
Cancer; 2011 Apr; 117(7):1334-49. PubMed ID: 21425133
[TBL] [Abstract][Full Text] [Related]
19. Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
Budd AC; Rhodes M; Forster AJ; Noghani P; Carrier M; Wells PS
Thromb Res; 2021 Jan; 197():144-152. PubMed ID: 33217622
[TBL] [Abstract][Full Text] [Related]
20. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
